Frequency of pruritus in plasmodium vivax malaria patients treated with chloroquine in thailand

Tropical Doctor

Volumn 30, Issue 4, 2000, Pages 211-214

  Bussaratid, Valai ^a   Walsh, Douglas S ^b   Wilairatana, Polrat ^a   Krudsood, Sivicha ^a   Silachamroon, Udomsak ^a   Looareesuwan, Sornchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALARIA; MALE; PLASMODIUM VIVAX; PRURITUS; THAILAND;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHLOROQUINE; DRUG ERUPTIONS; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MEDICAL RECORDS; MIDDLE AGED; PLASMODIUM VIVAX; PREVALENCE; PRURITUS; RETROSPECTIVE STUDIES; THAILAND;

EID: 0033776202     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947550003000410     Document Type: Article

References (30)

1. Brasseur P, Agnamey P, Ekobo AS, Samba G, Favennec L, Kouamouo J. Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro. Trans R Soc Trop Med Hyg, 1995;89:528-30.
2. Wilairatana P, Looareesuwan S, Walsh DS. Chemotherapy of cerebral malaria: current recommendations for treatment and prophylaxis. CNS Drugs, 1997;7:366-80.
3. Wilairatana P, Looareesuwan S, Riganti M et al. Pustular eruption in a malaria patient treated with chloroquine. Int J Dermatol, 1997;36:634-5.
4. Abila B, Ikueze R. Effects of clemastine, ketotifen and prednisolone on chloroquine-induced pruritus. J Trop Med Hyg, 1989;92:356-9.
5. Essien EE, Ette EI, Thomas WO, Brown-Awala EA. Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus. Eur J Drug Metab Pharmacokinet, 1989;14:71-7.
6. George AO. Chloroquine pruritus: a possible fixed cutaneous reaction. Int J Dermatol, 1996;35:323-4.
7. Harries AD, Chugh KS. Chloroquine-induced pruritus in Nigerian medical and nursing students. Ann Trop Med Parasitol, 1986;80:479-82.
8. Mnyika KS, Kihamia CM. Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam. J Trop Med Hyg, 1991;94:27-31.
9. Ogunranti JO, Aguiyi JC, Roma S, Onwukeme KE. Chloroquine-induced pruritus and sickle cell gene trait in Africans: possible pharmacogenetic relationship. Eur J Clin Pharmacol, 1992;43:323-4.
10. Spencer HC, Kaseje DC, Brandling-Bennett AD, Oloo AJ, Watkins WM. Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. Ann Trop Med Parasitol, 1987;81:124-7.
11. Olatunde A. The practical and therapeutic implications of chloroquine-induced itching in tropical Africa. Afr J Med Sci, 1977;6:27-32.
12. Buszman E, Kopera M, Wilczok T. Electron spin resonance studies of chloroquine-melanin complexes. Biochem Pharmacol, 1984;33:7-11.
13. Larsson B, Tjalve H. Studies on the mechanism of drug-binding to melanin. Biochem Pharmacol, 1979;28:1181-7.
14. Sams WM Jr, Epstein JH. The affinity of melanin for chloroquine. J Invest Dermatol, 1965;45:482-7.
15. Swanbeck G. Aminoquinolines. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999:2794-7.
16. Tanenbaum L, Tuffanelli DL. Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol, 1980;116:587-91.
17. Sjolin-Forsberg G, Berne B, Blixt C, Johansson M, Lindstrom B. Chloroquine phosphate: a long-term follow-up of drug concentrations in skin suction blister fluid and plasma. Acta Derm Venereol, 1993;73:426-9.
18. Sowunmi A, Walker O, Salako LA. Pruritus and antimalarial drugs in Africans. Lancet, 1989;ii:213.
19. Olatunde A, Obih PO. Use and misuse of 4-aminoquinoline antimalarials in tropical Africa and re-examination of itch reaction to these drugs. Trop Doct, 1981;11:97-101.
20. Osifo NG. The antipruritic effects of chlorpheniramine, cyproheptadine and sulphapyridine monitored with limb activity meters on chloroquine induced pruritus among patients with malaria. Afr J Med Sci, 1995;24:67-73.
21. Osifo NG. Structure activity relationships in the pruritogenicity of chloroquine and amodiaquine metabolites in a dog model. J Dermatol Sci, 1991;2:92-6.
22. Okor RS. Responsiveness of chloroquine-induced pruritus to antihistamine therapy — a clinical survey. J Clin Pharm Ther, 1990;15:147-50.
23. Okor RS. Onset of pruritogenicity of chloroquine and the implication for the timing of suppressive therapy. J Clin Pharm Ther, 1991;16:463-5.
24. Osifo NG. Chloroquine-induced pruritus among patients with malaria. Arch Dermatol, 1984;120:80-2.
25. Spencer HC, Poulter NR, Lury JD, Poulter CJ. Chloroquine-associated pruritus in a European. BMJ, 1982;285:1703-4.
26. Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB. Biology of melanocytes. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999:192-220.
27. Sjolin-Forsberg G, Berne B, Johansson M, Olsson MJ, Rollman O. Differential uptake of chloroquine by human keratinocytes and melanocytes in culture. Arch Dermatol Res, 1996;288:211-15.
28. Sjolin-Forsberg G, Hansson C, Kagedal B, Gannedahl EL, Berne B. Urinary excretion of melanocyte metabolites during treatment with chloroquine phosphate. Acta Derm Venereol, 1995;75:287-9.
29. Olatunde IA. Chloroquine concentrations in the skin of rabbits and man. Br J Pharmacol, 1971;43:334-40.
30. Greaves MW, Wall PD. Pathophysiology and clinical aspects of pruritus. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999:487-94.